AIN
Entac Medical Inc.

Entac Medical Inc.

location_on South East ,  United States

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

Highlights

  • PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
  • In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
  • Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.
  • Interest: 27 systems (328 hospitals)-$119M opportunity. Expected 2025-26.
  • 80 systems (~1000 hospitals) engaged with PrevisEA at all sales stages

Overview

Target $2,000,000
Minimum $50,000
Investment Raised $800,000
Previous Rounds $8,000,000
Stage Achieving Sales
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects